Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dovitinib in Metastatic HER2-Negative Breast Cancer
NCT00958971Phase 2Completed
- Sponsor
- Novartis
- Start
- Jul 2009
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of dovitinib in breast cancer, sponsored by Novartis. Started Jul 2009; status: completed.
02
Drugs
dovitinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00958971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00958971.